330 related articles for article (PubMed ID: 25956840)
41. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
[TBL] [Abstract][Full Text] [Related]
42. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
Alinaghi F; Tekin HG; Burisch J; Wu JJ; Thyssen JP; Egeberg A
J Crohns Colitis; 2020 Mar; 14(3):351-360. PubMed ID: 31504363
[TBL] [Abstract][Full Text] [Related]
43. Role of genetic and environmental factors in British twins with inflammatory bowel disease.
Ng SC; Woodrow S; Patel N; Subhani J; Harbord M
Inflamm Bowel Dis; 2012 Apr; 18(4):725-36. PubMed ID: 21557397
[TBL] [Abstract][Full Text] [Related]
44. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
45. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
Cholapranee A; Ananthakrishnan AN
Inflamm Bowel Dis; 2016 Sep; 22(9):2191-9. PubMed ID: 27482977
[TBL] [Abstract][Full Text] [Related]
46. Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease.
Li Z; Qiao L; Yun X; Du F; Xing S; Yang M
Z Gastroenterol; 2021 Feb; 59(2):117-124. PubMed ID: 33233007
[TBL] [Abstract][Full Text] [Related]
47. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
Marín AC; Gisbert JP; Chaparro M
World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
49. Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studies.
Huai JP; Ding J; Ye XH; Chen YP
Asian Pac J Cancer Prev; 2014; 15(8):3477-82. PubMed ID: 24870743
[TBL] [Abstract][Full Text] [Related]
50. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
[TBL] [Abstract][Full Text] [Related]
51. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
Chiarella-Redfern H; Lee S; Jubran B; Sharifi N; Panaccione R; Constantinescu C; Benchimol EI; Seow CH
Inflamm Bowel Dis; 2022 Jan; 28(1):79-86. PubMed ID: 33609034
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory bowel disease and risk of Parkinson's disease: evidence from a meta-analysis of 14 studies involving more than 13.4 million individuals.
Li HX; Zhang C; Zhang K; Liu YZ; Peng XX; Zong Q
Front Med (Lausanne); 2023; 10():1137366. PubMed ID: 37153103
[TBL] [Abstract][Full Text] [Related]
53. Is Vaccination Against COVID-19 Associated With Inflammatory Bowel Disease Flare? Self-Controlled Case Series Analysis Using the UK CPRD.
Card TR; Nakafero G; Grainge MJ; Mallen CD; Van-Tam JSN; Williams HC; Abhishek A
Am J Gastroenterol; 2023 Aug; 118(8):1388-1394. PubMed ID: 36826512
[TBL] [Abstract][Full Text] [Related]
54. [Vaccination in childhood. Indications towards change].
Stephan U
Fortschr Med; 1977 Feb; 95(5):253-5. PubMed ID: 838443
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia.
Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P; Barr G; Jones B; Connor S; Paven G; Chapman G; Park G; Gearry R; Leong RW;
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1453-63.e1. PubMed ID: 25771246
[TBL] [Abstract][Full Text] [Related]
56. Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection.
Fleurier A; Pelatan C; Willot S; Ginies JL; Breton E; Bridoux L; Segura JF; Chaillou E; Jobert A; Darviot E; Cagnard B; Delaperriere N; Grimal I; Carre E; Wagner AC; Sylvestre E; Dabadie A
Dig Liver Dis; 2015 Jun; 47(6):460-4. PubMed ID: 25770456
[TBL] [Abstract][Full Text] [Related]
57. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso.
Pfeiffer G; Fisker AB; Nebié E; Hengelbrock J; Sié A; Becher H; Müller O
Vaccine; 2017 Dec; 35(51):7114-7120. PubMed ID: 29153586
[TBL] [Abstract][Full Text] [Related]
58. Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Xiao Z; Pei Z; Yuan M; Li X; Chen S; Xu L
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2774-80. PubMed ID: 26360973
[TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
Dominicus R; Galtier F; Richard P; Baudin M
Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
